Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Clinical trial NCT02710734 · COMPLETED

Trial details

NCT number: NCT02710734
Sponsor: Fox Chase Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Carcinoma of the Bladder

Start date: 2016-02-24
Primary completion: 2025-11-27
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.